Repositorio Dspace

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Mostrar el registro sencillo del ítem

dc.contributor.author Tur, Carmen
dc.contributor.author Dubessy, Anne-Laure
dc.contributor.author Otero-Romero, Susana
dc.contributor.author Amato, María Pía
dc.contributor.author Derfuss, Tobías
dc.contributor.author Di Pauli, Franziska
dc.contributor.author Iacobaeus, Ellen
dc.contributor.author Mycko, Marcin
dc.contributor.author Abboud, Hesham
dc.contributor.author Achiron, Anat
dc.contributor.author Bellinvia, Angelo
dc.contributor.author Boyko, Alexey
dc.contributor.author Casanova, Jean-Laurent
dc.contributor.author Clifford, David
dc.contributor.author Dobson, Ruth
dc.contributor.author Farez, Mauricio Franco
dc.contributor.author Filippi, Massimo
dc.contributor.author Fitzgerald, Kathryn C.
dc.contributor.author Fonderico, Mattia
dc.contributor.author Gouider, Riadh
dc.date.accessioned 2023-12-20T14:04:57Z
dc.date.available 2023-12-20T14:04:57Z
dc.date.issued 2022-02-23
dc.identifier.citation Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M, Abboud H, Achiron A, Bellinvia A, Boyko A, Casanova JL, Clifford D, Dobson R, Farez MF, Filippi M, Fitzgerald KC, Fonderico M, Gouider R, Hacohen Y, Hellwig K, Hemmer B, Kappos L, Ladeira F, Lebrun-Frénay C, Louapre C, Magyari M, Mehling M, Oreja-Guevara C, Pandit L, Papeix C, Piehl F, Portaccio E, Ruiz-Camps I, Selmaj K, Simpson-Yap S, Siva A, Sorensen PS, Sormani MP, Trojano M, Vaknin-Dembinsky A, Vukusic S, Weinshenker B, Wiendl H, Winkelmann A, Zuluaga Rodas MI, Tintoré M, Stankoff B. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021. Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. es_ES
dc.identifier.uri https://doi.org/10.1177/13524585211069068
dc.identifier.uri https://repositorio.fleni.org.ar/xmlui/handle/123456789/927
dc.description.abstract Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease-modifying treatments (DMTs) are now available. However, most DMTs are associated with adverse events, the most frequent of which being infections. Consideration of all DMT-associated risks facilitates development of risk mitigation strategies. An international focused workshop with expert-led discussions was sponsored by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and was held in April 2021 to review our current knowledge about the risk of infections associated with the use of DMTs for people with MS and NMOSD and corresponding risk mitigation strategies. The workshop addressed DMT-associated infections in specific populations, such as children and pregnant women with MS, or people with MS who have other comorbidities or live in regions with an exceptionally high infection burden. Finally, we reviewed the topic of DMT-associated infectious risks in the context of the current SARS-CoV-2 pandemic. Herein, we summarize available evidence and identify gaps in knowledge which justify further research. es_ES
dc.language.iso eng es_ES
dc.publisher Stockton Press es_ES
dc.subject Multiple Sclerosis es_ES
dc.subject Esclerosis Múltiple es_ES
dc.title The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021 es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.description.fil Fil: Farez, Mauricio Franco. Fleni. Centro para la Investigación de Enfermedades Neuroinmunológicas; Argentina.
dc.description.fil Fil: Tur, Carmen. Vall d'Hebron Barcelona Hospital Campus; España.
dc.description.fil Fil: Dubessy, Anne-Laure. Saint Antoine Hospital; Francia.
dc.description.fil Fil: Otero-Romero, Susana. Vall d'Hebron Barcelona Hospital Campus; España.
dc.description.fil Fil: Amato, María Pía. University of Florence; Italia.
dc.description.fil Fil: Derfuss, Tobías. University of Basel; Suiza.
dc.description.fil Fil: Di Pauli, Franziska. Medical University of Innsbruck; Austria.
dc.description.fil Fil: Iacobaeus, Ellen. Karolinska Institutet and Karolinska University Hospital; Suecia.
dc.description.fil Fil: Mycko, Marcin. University of Warmia; Polonia.
dc.description.fil Fil: Abboud, Hesham. Cleveland Medical Center; Estados Unidos.
dc.description.fil Fil: Achiron, Anat. Tel Aviv University; Israel.
dc.description.fil Fil: Bellinvia, Angelo. University of Florence; Italia.
dc.description.fil Fil: Boyko, Alexey. Federal Center of Brain Research and Neurotechnologie; Rusia.
dc.description.fil Fil: Casanova, Jean-Laurent. The Rockefeller University; Estados Unidos.
dc.description.fil Fil: Clifford, David. Washington University in St. Louis; Estados Unidos.
dc.description.fil Fil: Dobson, Ruth. Royal London Hospital; Reino Unido.
dc.description.fil Fil: Filippi, Massimo. Italy/Vita-Salute San Raffaele University; Italia.
dc.description.fil Fil: Fitzgerald, Kathryn C. Johns Hopkins University; Estados Unidos.
dc.description.fil Fil: Gouider, Riadh. Razi Hospital; Túnez.
dc.relation.ispartofVOLUME 28
dc.relation.ispartofNUMBER 9
dc.relation.ispartofPAGINATION 1424-1456.
dc.relation.ispartofCOUNTRY Reino Unido
dc.relation.ispartofCITY Londres
dc.relation.ispartofTITLE Multiple sclerosis : clinical and laboratory research
dc.relation.ispartofISSN 1477-0970
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Listar

Mi cuenta

Estadísticas